Retatrutide, the newest type of weight-loss drug, helped people lose an average of 70 pounds or about 30% of their body weight over 80 weeks, according to study data from the drugs manufacturer
Still, its worth noting a few potential issues
Issue: Difficulty obtaining quality peptides Vendor problems: Research chemical vendors with inconsistent quality, counterfeit products, international shipping seizures, high costs for pharmaceutical-grade sources
Because of this, more comprehensive data from human clinical trials are needed to produce response guidelines. Interaction Potential: A crucial part of any testing process is to look for interaction possibilities, eg, where is the peptide affecting that it wasnt designed to
You could lose up to 22.7% of your body weight on CagriSema over 68 weeks, based on data from early clinical trials